Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
2.

Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.

Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):362-73. doi: 10.1007/s00259-015-3208-1. Epub 2015 Oct 6. Review.

PMID:
26440450
3.

Amyloid Imaging: Poised for Integration into Medical Practice.

Anand K, Sabbagh M.

Neurotherapeutics. 2017 Jan;14(1):54-61. doi: 10.1007/s13311-016-0474-y. Review.

PMID:
27571940
4.

[Molecular imaging of beta-amyloid plaques in the brain].

Ono M.

Brain Nerve. 2007 Mar;59(3):233-40. Review. Japanese.

PMID:
17370649
5.

Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.

Leuzy A, Zimmer ER, Heurling K, Rosa-Neto P, Gauthier S.

Amyloid. 2014 Sep;21(3):143-8. doi: 10.3109/13506129.2014.926267. Epub 2014 Jun 11. Review.

PMID:
24919109
6.

Current status of PET-imaging probes of β-amyloid plaques.

Koo J, Byun Y.

Arch Pharm Res. 2013 Oct;36(10):1178-84. doi: 10.1007/s12272-013-0193-4. Epub 2013 Jul 1. Review.

PMID:
23812777
7.

Molecular neuroimaging in degenerative dementias.

Jiménez Bonilla JF, Carril Carril JM.

Rev Esp Med Nucl Imagen Mol. 2013 Sep-Oct;32(5):301-9. doi: 10.1016/j.remn.2013.06.012. Epub 2013 Aug 9. Review. English, Spanish.

8.
9.

Radiolabeled peptides for Alzheimer's diagnostic imaging: mini review.

Barrios-Lopez B, Raki M, Bergström K.

Curr Radiopharm. 2013 Dec;6(4):181-91. Review.

PMID:
24283961
10.

Impact of amyloid imaging on drug development in Alzheimer's disease.

Mathis CA, Lopresti BJ, Klunk WE.

Nucl Med Biol. 2007 Oct;34(7):809-22. Epub 2007 Sep 4. Review.

12.

Development of positron emission tomography β-amyloid plaque imaging agents.

Mathis CA, Mason NS, Lopresti BJ, Klunk WE.

Semin Nucl Med. 2012 Nov;42(6):423-32. doi: 10.1053/j.semnuclmed.2012.07.001. Review.

13.

FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?

Mosconi L, McHugh PF.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):250-64. Review.

14.

Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

Morris E, Chalkidou A, Hammers A, Peacock J, Summers J, Keevil S.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):374-85. doi: 10.1007/s00259-015-3228-x. Epub 2015 Nov 28. Review.

15.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
16.

Development and evaluation of compounds for imaging of beta-amyloid plaque by means of positron emission tomography.

Henriksen G, Yousefi BH, Drzezga A, Wester HJ.

Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S75-81. doi: 10.1007/s00259-007-0705-x. Review.

PMID:
18224319
17.

Amyloid plaque imaging from IMPY/SPECT to AV-45/PET.

Kung MP, Weng CC, Lin KJ, Hsiao IT, Yen TC, Wey SP.

Chang Gung Med J. 2012 May-Jun;35(3):211-8. Review.

PMID:
22735052
18.

Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus.

Arbizu J, García-Ribas G, Carrió I, Garrastachu P, Martínez-Lage P, Molinuevo JL.

Rev Esp Med Nucl Imagen Mol. 2015 Sep-Oct;34(5):303-13. doi: 10.1016/j.remn.2015.03.002. Epub 2015 Jun 20. English, Spanish.

19.

5-(2E,4E)-5-(6-hydroxy-4-oxo-2-thioxo-1,2,3,4-tetrahydroxy-5 pyrimidinyl)-2,4-pentadienylidene-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Jul 1 [updated 2012 Oct 25].

20.

Technical Considerations in Brain Amyloid PET Imaging with 18F-Florbetapir.

Trembath L, Newell M, Devous MD Sr.

J Nucl Med Technol. 2015 Sep;43(3):175-84. doi: 10.2967/jnmt.115.156679. Epub 2015 Aug 13. Review.

Supplemental Content

Support Center